Cargando…

Brain-derived neurotrophic factor plasma levels are associated with mortality in critically ill patients even in the absence of brain injury

INTRODUCTION: Because of its relevance to the functioning of the central nervous system, brain-derived neurotrophic factor (BDNF) has been implicated in the pathogenesis of different neuropsychiatric diseases. Whether the BDNF level can be a marker of brain dysfunction and thus predict mortality in...

Descripción completa

Detalles Bibliográficos
Autores principales: Ritter, Cristiane, Miranda, Aline S, Giombelli, Vinícius Renê, Tomasi, Cristiane D, Comim, Clarissa M, Teixeira, Antonio Lucio, Quevedo, João, Dal-Pizzol, Felipe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3672623/
https://www.ncbi.nlm.nih.gov/pubmed/23245494
http://dx.doi.org/10.1186/cc11902
_version_ 1782272141632208896
author Ritter, Cristiane
Miranda, Aline S
Giombelli, Vinícius Renê
Tomasi, Cristiane D
Comim, Clarissa M
Teixeira, Antonio Lucio
Quevedo, João
Dal-Pizzol, Felipe
author_facet Ritter, Cristiane
Miranda, Aline S
Giombelli, Vinícius Renê
Tomasi, Cristiane D
Comim, Clarissa M
Teixeira, Antonio Lucio
Quevedo, João
Dal-Pizzol, Felipe
author_sort Ritter, Cristiane
collection PubMed
description INTRODUCTION: Because of its relevance to the functioning of the central nervous system, brain-derived neurotrophic factor (BDNF) has been implicated in the pathogenesis of different neuropsychiatric diseases. Whether the BDNF level can be a marker of brain dysfunction and thus predict mortality in critically ill patients is not known. Thus we aimed to determine whether the plasma levels of BDNF are associated with morbidity and mortality in critically ill patients. METHODS: Healthy volunteers (n = 40) and consecutive patients older than 18 years (n = 76) admitted for more than 24 hours in an Intensive Care Unit (ICU) in a University hospital between July and October 2010 were included in the present study. First blood samples were collected within 12 hours of enrollment (D0), and a second sample, 48 hours after (D2) for determination of plasma BDNF levels. The relation between BDNF levels and mortality was the primary outcome. The secondary outcomes were the relation between BDNF levels and delirium and coma-free days (DCFD) and ICU and hospital length of stay (LOS). RESULTS: Admission plasma levels of BDNF were higher in ICU patients when compared with healthy volunteers (1,536 (962) versus 6,565 (2,838) pg/ml). The mean BDNF D2 was significantly lower in nonsurvivor patients (5,865 (2,662) versus 6,741 (2,356) pg/ml). After adjusting for covariates, BDNF levels, the need for mechanical ventilation, and sepsis were associated with mortality. Even in patients without clinically detectable brain dysfunction, lower BDNF D2 levels were associated with mortality. BDNF D2 had a mild correlation to DCFD (r = 0.44), but not to ICU and hospital LOS. In addition, plasma BDNF did not correlate to different plasma cytokines and platelets levels. CONCLUSIONS: The plasma levels of BDNF were independently associated with mortality, even in the absence of clinically detectable brain dysfunction.
format Online
Article
Text
id pubmed-3672623
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-36726232013-06-10 Brain-derived neurotrophic factor plasma levels are associated with mortality in critically ill patients even in the absence of brain injury Ritter, Cristiane Miranda, Aline S Giombelli, Vinícius Renê Tomasi, Cristiane D Comim, Clarissa M Teixeira, Antonio Lucio Quevedo, João Dal-Pizzol, Felipe Crit Care Research INTRODUCTION: Because of its relevance to the functioning of the central nervous system, brain-derived neurotrophic factor (BDNF) has been implicated in the pathogenesis of different neuropsychiatric diseases. Whether the BDNF level can be a marker of brain dysfunction and thus predict mortality in critically ill patients is not known. Thus we aimed to determine whether the plasma levels of BDNF are associated with morbidity and mortality in critically ill patients. METHODS: Healthy volunteers (n = 40) and consecutive patients older than 18 years (n = 76) admitted for more than 24 hours in an Intensive Care Unit (ICU) in a University hospital between July and October 2010 were included in the present study. First blood samples were collected within 12 hours of enrollment (D0), and a second sample, 48 hours after (D2) for determination of plasma BDNF levels. The relation between BDNF levels and mortality was the primary outcome. The secondary outcomes were the relation between BDNF levels and delirium and coma-free days (DCFD) and ICU and hospital length of stay (LOS). RESULTS: Admission plasma levels of BDNF were higher in ICU patients when compared with healthy volunteers (1,536 (962) versus 6,565 (2,838) pg/ml). The mean BDNF D2 was significantly lower in nonsurvivor patients (5,865 (2,662) versus 6,741 (2,356) pg/ml). After adjusting for covariates, BDNF levels, the need for mechanical ventilation, and sepsis were associated with mortality. Even in patients without clinically detectable brain dysfunction, lower BDNF D2 levels were associated with mortality. BDNF D2 had a mild correlation to DCFD (r = 0.44), but not to ICU and hospital LOS. In addition, plasma BDNF did not correlate to different plasma cytokines and platelets levels. CONCLUSIONS: The plasma levels of BDNF were independently associated with mortality, even in the absence of clinically detectable brain dysfunction. BioMed Central 2012 2012-12-17 /pmc/articles/PMC3672623/ /pubmed/23245494 http://dx.doi.org/10.1186/cc11902 Text en Copyright ©2012 Ritter et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Ritter, Cristiane
Miranda, Aline S
Giombelli, Vinícius Renê
Tomasi, Cristiane D
Comim, Clarissa M
Teixeira, Antonio Lucio
Quevedo, João
Dal-Pizzol, Felipe
Brain-derived neurotrophic factor plasma levels are associated with mortality in critically ill patients even in the absence of brain injury
title Brain-derived neurotrophic factor plasma levels are associated with mortality in critically ill patients even in the absence of brain injury
title_full Brain-derived neurotrophic factor plasma levels are associated with mortality in critically ill patients even in the absence of brain injury
title_fullStr Brain-derived neurotrophic factor plasma levels are associated with mortality in critically ill patients even in the absence of brain injury
title_full_unstemmed Brain-derived neurotrophic factor plasma levels are associated with mortality in critically ill patients even in the absence of brain injury
title_short Brain-derived neurotrophic factor plasma levels are associated with mortality in critically ill patients even in the absence of brain injury
title_sort brain-derived neurotrophic factor plasma levels are associated with mortality in critically ill patients even in the absence of brain injury
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3672623/
https://www.ncbi.nlm.nih.gov/pubmed/23245494
http://dx.doi.org/10.1186/cc11902
work_keys_str_mv AT rittercristiane brainderivedneurotrophicfactorplasmalevelsareassociatedwithmortalityincriticallyillpatientsevenintheabsenceofbraininjury
AT mirandaalines brainderivedneurotrophicfactorplasmalevelsareassociatedwithmortalityincriticallyillpatientsevenintheabsenceofbraininjury
AT giombelliviniciusrene brainderivedneurotrophicfactorplasmalevelsareassociatedwithmortalityincriticallyillpatientsevenintheabsenceofbraininjury
AT tomasicristianed brainderivedneurotrophicfactorplasmalevelsareassociatedwithmortalityincriticallyillpatientsevenintheabsenceofbraininjury
AT comimclarissam brainderivedneurotrophicfactorplasmalevelsareassociatedwithmortalityincriticallyillpatientsevenintheabsenceofbraininjury
AT teixeiraantoniolucio brainderivedneurotrophicfactorplasmalevelsareassociatedwithmortalityincriticallyillpatientsevenintheabsenceofbraininjury
AT quevedojoao brainderivedneurotrophicfactorplasmalevelsareassociatedwithmortalityincriticallyillpatientsevenintheabsenceofbraininjury
AT dalpizzolfelipe brainderivedneurotrophicfactorplasmalevelsareassociatedwithmortalityincriticallyillpatientsevenintheabsenceofbraininjury